Theravance Biopharma, Inc. Other Non-Current Liabilities
Theravance Biopharma, Inc. (TBPH) had Other Non-Current Liabilities of $244.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-11
- 2026-06-30: Other Liabilities, Noncurrent $244.00K.
- 2026-03-31: Other Liabilities, Noncurrent $244.00K.
- 2025-12-31: Other Liabilities, Noncurrent $313.00K.
- 2025-09-30: Other Liabilities, Noncurrent $313.00K.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $244.00K 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $244.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $313.00K 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $313.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.55M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $1.29M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $1.89M 10-K · filed 2026-03-23 | |
| 2024-09-30 | $4.98M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $4.88M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $5.45M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $5.92M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $7.68M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $7.68M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $7.68M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $1.66M 10-K · filed 2024-03-01 | |
| 2022-09-30 | $1.66M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $2.40M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $2.43M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $2.18M 10-K · filed 2023-03-01 | $2.42M 10-K · filed 2022-02-28 |
| 2021-09-30 | $2.61M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $1.83M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $2.06M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $1.83M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $9.70M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $9.61M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $9.58M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $21.29M 10-K · filed 2021-02-26 | |
| 2019-09-30 | $8.90M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $14.46M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $14.26M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $24.76M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $28.32M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $28.32M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $36.09M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $34.82M 10-K · filed 2019-02-28 | $36.26M 10-K · filed 2018-02-28 |
| 2017-09-30 | $26.49M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $19.00M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $18.49M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $13.11M 10-K · filed 2018-02-28 | |
| 2016-09-30 | $8.85M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $3.88M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $3.74M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $2.98M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $2.79M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $2.43M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $1.89M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $1.58M 10-K · filed 2016-03-11 | |
| 2014-09-30 | $986.00K 10-Q · filed 2014-11-12 | |
| 2013-12-31 | $585.00K 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |